Tyra Biosciences, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold138K000000126K
Gross Profit-138K000000-126K
R&D Expenses33.3M28.2M25.5M24.3M25.0M22.2M22.7M17.9M
Operating Expenses41.9M36.5M32.9M31.5M31.9M29.7M28.6M23.4M
Operating Income-42.0M-36.5M-32.9M-31.5M-31.9M-29.7M-28.6M-23.5M
Other Income / Gains2.7M2.7M3.1M3.4M3.7M4.2M4.6M4.8M
Net Income-39.3M-33.8M-29.9M-28.1M-28.1M-25.6M-24.0M-18.7M
EPS (Diluted)-0.64-0.57-0.50-0.47-0.47-0.43-0.41-0.32
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses8.5M8.3M7.5M7.1M6.9M7.6M5.9M5.5M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses8.5M8.3M7.5M7.1M6.9M7.6M5.9M5.5M
Other Expenses00000000
Cost And Expenses42.0M36.5M32.9M31.5M31.9M29.7M28.6M23.5M
Interest Income2.7M2.7M03.4M3.7M4.2M4.6M4.8M
Interest Expense00000000
Depreciation And Amortization138K132K131K140K143K144K127K126K
Ebitda-39.2M-33.7M-29.7M-28.0M-28.0M-25.4M-23.9M-18.6M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-39.3M-33.8M-29.9M-28.1M-28.1M-25.6M-24.0M-18.7M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.64-0.57-0.50-0.47-0.47-0.43-0.41-0.32
Weighted Average Shs Out61.7M59.6M59.7M59.6M59.3M58.9M58.9M58.7M
Weighted Average Shs Out Dil61.7M59.6M59.7M59.6M59.3M58.9M58.9M58.7M